IL6R and Headache: Concerning the comparison between Ctrl and Anti-IL-6-R, respiratory comorbidities, headache, asthenia, arthralgia, syncope, Raynaud’s phenomenon, oxygen therapy, post-COVID diarrhea, post-COVID headache, post-COVID cough and post-COVID dyspnea on exertion entered the ranked ANCOVA.